Jessica Ann Palakshappa, MD, MS
- Assistant Professor, Pulmonary, Critical Care, Allergy, and Immunologic Diseases

Jessica Ann Palakshappa, MD, MS
- Education
- MD, University of Pennsylvania Health System, 2010
- Internship
- Massachusetts General Hospital, 2011
- Residency
- Massachusetts General Hospital, 2013
- Fellowship
- Critical Care, University of Pennsylvania Health System, 2016
- Board Certifications
- American Board of Internal Medicine, Critical Care Medicine
- American Board of Internal Medicine, Internal Medicine
- American Board of Internal Medicine, Pulmonary Disease
- Positions
- Assistant Professor, Pulmonary, Critical Care, Allergy, and Immunologic Diseases
- Departments and Affiliations
- Pulmonary, Critical Care, Allergy, and Immunologic Diseases
- Critical Illness, Injury and Recovery Research Center
- Sticht Center for Healthy Aging and Alzheimer's Prevention
- Center for Healthcare Innovation
- Maya Angelou Center for Health Equity
Research
- Bedside Ultrasonography Can and Should Be Used in the Intensive Care Unit to Evaluate Muscle Atrophy. Palakshappa JA, Bakhru RN. Ann Am Thorac Soc. 2019 09; 16(9):1107-1111.
- Plasma angiopoietin-2 as a potential causal marker in sepsis-associated ARDS development: evidence from Mendelian randomization and mediation analysis. Reilly JP, Wang F, Jones TK, Palakshappa JA, Anderson BJ, Shashaty MGS, Dunn TG, Johansson ED, Riley TR, Lim B, Abbott J, Ittner CAG, Cantu E, Lin X, Mikacenic C, Wurfel MM, Christiani DC, Calfee CS, Matthay MA, Christie JD, Feng R, Meyer NJ. Intensive Care Med. 2018 Nov; 44(11):1849-1858.
- Quantitative peripheral muscle ultrasound in sepsis: Muscle area superior to thickness. Palakshappa JA, Reilly JP, Schweickert WD, Anderson BJ, Khoury V, Shashaty MG, Fitzgerald D, Forker C, Butler K, Ittner CA, Feng R, Files DC, Bonk MP, Christie JD, Meyer NJ. J Crit Care. 2018 10; 47:324-330.
- Long-Term Outcomes After Extracorporeal Life Support for Acute Respiratory Failure. McDonald MD, Sandsmark DK, Palakshappa JA, Mikkelsen ME, Anderson BJ, Gutsche JT. J. Cardiothorac. Vasc. Anesth. 2019 Jan; 33(1):72-79.
- Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma Concentration. Meyer NJ, Reilly JP, Anderson BJ, Palakshappa JA, Jones TK, Dunn TG, Shashaty MGS, Feng R, Christie JD, Opal SM. Crit. Care Med. 2018 01; 46(1):21-28.